Substrates for peptidase S01.233: plasmin
Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.
| Substrate | Uniprot | Residue range | Cleavage Site | Cleavage type | Evidence | P4 | P3 | P2 | P1 | P1' | P2' | P3' | P4' | Reference | CutDB | MERNUM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ac-Ala-Arg-Phe-Lys-ACC | Ac-Ala-Arg-Phe-Lys+ACC | S | Ala | Arg | Phe | Lys | ACC | - | - | - | Gosalia et al., 2005 | |||||
| Ac-Ala-Arg-Tyr-Arg-ACC | Ac-Ala-Arg-Tyr-Arg+ACC | S | Ala | Arg | Tyr | Arg | ACC | - | - | - | Gosalia et al., 2005 | |||||
| aggrecan core protein | P16112 | 17-2415 | peptide-Arg394+Gly-peptide | P | Gly | Glu | Ala | Arg | Gly | Ser | Val | Ile | Fosang et al., 1998 | 18239 | ||
| alpha-2-antiplasmin | P08697 | 24-402 | peptide-Arg403+Met-peptide | P | Ala | Met | Ser | Arg | Met | Ser | Leu | Ser | Holmes et al., 1987 | 24033 | ||
| alpha-2-macroglobulin | P01023 | 24-1474 | peptide-Arg719+Leu-peptide | P | Gly | His | Ala | Arg | Leu | Val | His | Val | Mortensen et al., 1981 | |||
| anti-Mullerian hormone | P03971 | 26-560 | peptide-Arg451+Ser-peptide | P | Arg | Ala | Gln | Arg | Ser | Ala | Gly | Ala | Maggard et al., 1996 | 18834 | ||
| arginyl bond | peptide-Arg+peptide | N | - | - | NPe | Arg | CPe | - | - | - | Castellino, 2004 | |||||
| beta-2-glycoprotein 1 | P02749 | 20-345 | peptide-Lys336+Thr-peptide | P | Ala | Phe | Trp | Lys | Thr | Asp | Ala | Ser | Ohkura et al., 1998 | 3416 | ||
| beta-amyloid protein 40 | P05067 | 672-711 | peptide-Arg676+His-peptide | P | MS | Ala | Glu | Phe | Arg | His | Asp | Ser | Gly | Tucker et al., 2000 | ||
| beta-amyloid protein 40 | P05067 | 672-711 | peptide-Lys687+Leu-peptide | P | MS | His | His | Gln | Lys | Leu | Val | Phe | Phe | Tucker et al., 2000 | ||
| beta-amyloid protein 40 | P05067 | 672-711 | peptide-Lys699+Gly-peptide | P | MS | Gly | Ser | Asn | Lys | Gly | Ala | Ile | Ile | Tucker et al., 2000 | ||
| Boc-Glu-Lys-Lys-Mca | Boc-Glu-Lys-Lys+Mca | S | Boc | Glu | Lys | Lys | Mca | - | - | - | Kato et al., 1980 | |||||
| Boc-Val-Leu-Lys-Mca | Boc-Val-Leu-Lys+Mca | S | Boc | Val | Leu | Lys | Mca | - | - | - | Kato et al., 1980 | |||||
| brain-derived neurotrophic factor precursor | P23560 | 19-247 | peptide-Arg125+Val-peptide | P | Met | Ser | Met | Arg | Val | Arg | Arg | His | Gray & Ellis, 2008 | 22593 | ||
| carboxypeptidase N | P15169 | 21-458 | peptide-Arg238+Arg-peptide | P | NT | Arg | Gly | Val | Arg | Arg | Thr | Ala | Ser | Quagraine et al., 2005 | ||
| carboxypeptidase N subunit 2 | P22792 | 22-545 | peptide-Arg478+Ser-peptide | P | NT | Arg | Ala | Ala | Arg | Ser | Gln | Cys | Thr | Quagraine et al., 2005 | ||
| ceruloplasmin | P00450 | 20-1065 | peptide-Arg500+Ser-peptide | P | NT | Pro | Gln | Ser | Arg | Ser | Val | Pro | Pro | Kingston et al., 1978 | 3408 | |
| ceruloplasmin | P00450 | 20-1065 | peptide-Lys906+Val-peptide | P | NT | Pro | Tyr | Leu | Lys | Val | Phe | Asn | Pro | Kingston et al., 1978 | 3407 | |
| chromogranin-A | P10645 | 19-457 | peptide-Arg377+Ala-peptide | P | Leu | Ser | Phe | Arg | Ala | Arg | Ala | Tyr | Jiang et al., 2001 | 18871 | ||
| chromogranin-A | P10645 | 19-457 | peptide-Arg391+Arg-peptide | P | Pro | Gln | Leu | Arg | Arg | Gly | Trp | Arg | Jiang et al., 2001 | 18872 | ||
| chromogranin-A | P10645 | 19-457 | peptide-Arg368+Asp-peptide | P | Glu | Asp | Asn | Arg | Asp | Ser | Ser | Met | Yuan et al., 2009 | 24727 | ||
| chromogranin-A | P10645 | 19-457 | peptide-Lys373+Leu-peptide | P | Ser | Ser | Met | Lys | Leu | Ser | Phe | Arg | Yuan et al., 2009 | 24728 | ||
| chromogranin-A | P10645 | 19-457 | peptide-Arg379+Ala-peptide | P | Phe | Arg | Ala | Arg | Ala | Tyr | Gly | Phe | Yuan et al., 2009 | 24729 | ||
| chromogranin-A | P10645 | 19-457 | peptide-Arg384+Gly-peptide | P | Tyr | Gly | Phe | Arg | Gly | Pro | Gly | Pro | Yuan et al., 2009 | 24730 | ||
| Coagulation factor VIII | P00451 | 20-2351 | Peptide-Lys55+Ser-Peptide | P | NT | Arg | Val | Pro | Lys | Ser | Phe | Pro | Phe | Nogami et al., 2007 | ||
| Coagulation factor VIII | P00451 | 20-2351 | Peptide-Arg355+Met-Peptide | P | NT | Pro | Gln | Leu | Arg | Met | Lys | Asn | Asn | Nogami et al., 2007 | ||
| Coagulation factor VIII | P00451 | 20-2351 | Peptide-Arg391+Ser-Peptide | P | NT | Ile | Gln | Ile | Arg | Ser | Val | Ala | Lys | Nogami et al., 2007 | ||
| Coagulation factor VIII | P00451 | 20-2351 | Peptide-Arg759+Ser-Peptide | P | NT | Ile | Glu | Pro | Arg | Ser | Phe | Ser | Gln | Nogami et al., 2007 | ||
| Coagulation factor VIII | P00451 | 20-2351 | Peptide-Arg1708+Ser-Peptide | P | NT | Gln | Ser | Pro | Arg | Ser | Phe | Gln | Lys | Nogami et al., 2007 | ||
| Coagulation factor VIII | P00451 | 20-2351 | Peptide-Arg1740+Ala-Peptide | P | NT | Leu | Arg | Asn | Arg | Ala | Gln | Ser | Gly | Nogami et al., 2007 | ||
| coagulation factor X light chain | P00742 | 41-488 | peptide-Arg335+Met-peptide | P | Ile | Thr | Phe | Arg | Met | Asn | Val | Ala | Pryzdial et al., 1999 | 24725 | ||
| coagulation factor Xa | P00742 | 41-179; 235-488 | peptide-Lys370+Gly-peptide | P | Thr | His | Glu | Lys | Gly | Arg | Gln | Ser | Pryzdial et al., 1999 | 17428 | ||
| Complement C3 alpha chain | P01024 | 672-1663 | peptide-Arg748+Ser-peptide | P | MS | Gly | Leu | Ala | Arg | Ser | Asn | Leu | Asp | Amara et al.,2010 | ||
| complement C5 | P01031 | 678-1676 | peptide-Arg751+Leu-peptide | P | MS | Gln | Leu | Gly | Arg | Leu | His | Met | Lys | Amara et al., 2010 | ||
| complement factor I | P05156 | 19-335; 340-583 | peptide-Lys344+Arg-peptide | N | Val | Gly | Gly | Lys | Arg | Ala | Gln | Leu | Tsiftsoglou et al., 2005 | |||
| complement factor I | P05156 | 19-335; 340-583 | peptide-Lys319+Ser-peptide | N | Arg | Arg | Ile | Lys | Ser | Leu | Leu | Pro | Tsiftsoglou et al., 2005 | |||
| complement factor I | P05156 | 19-335; 340-583 | peptide-Lys405+Arg-peptide | N | Pro | Asp | Leu | Lys | Arg | Ile | Val | Ile | Tsiftsoglou et al., 2005 | |||
| complement factor I | P05156 | 19-335; 340-583 | peptide-Arg339+Ile-peptide | N | Arg | Arg | Lys | Arg | Ile | Val | Gly | Gly | Tsiftsoglou et al., 2005 | |||
| complement factor I | P05156 | 19-335; 340-583 | peptide-Lys89+Ser-peptide | N | Cys | Gln | Gln | Lys | Ser | Leu | Glu | Cys | Tsiftsoglou et al., 2005 | |||
| complement factor I | P05156 | 19-335; 340-583 | peptide-Lys37+Tyr-peptide | N | Leu | Ala | Lys | Lys | Tyr | Thr | His | Leu | Tsiftsoglou et al., 2005 | |||
| complement factor I | P05156 | 19-335; 340-583 | peptide-Lys170+Leu-peptide | N | Arg | Arg | Phe | Lys | Leu | Ser | Asp | Leu | Tsiftsoglou et al., 2005 | |||
| complement factor I | P05156 | 19-335; 340-583 | peptide-Arg79+Arg-peptide | N | Ala | Thr | Asn | Arg | Arg | Ser | Phe | Pro | Tsiftsoglou et al., 2005 | |||
| complement factor I | P05156 | 19-335; 340-583 | peptide-Lys257+Ala-peptide | N | Leu | Cys | Cys | Lys | Ala | Cys | Gln | Gly | Tsiftsoglou et al., 2005 | |||
| complement factor I | P05156 | 19-335; 340-583 | peptide-Lys36+Lys-peptide | N | Cys | Leu | Ala | Lys | Lys | Tyr | Thr | His | Tsiftsoglou et al., 2005 | |||
| Elafin precursor | P19957 | 23-117 | peptide-Lys60+Ala-peptide | P | Asp | Lys | Val | Lys | Ala | Gln | Glu | Pro | Guyot et al., 2005 | 22162 | ||
| fibrinogen alpha chain precursor | P02671 | 19-866 | peptide-Arg123+Asp-peptide | P | NT | Ala | Asn | Asn | Arg | Asp | Asn | Thr | Tyr | Bini et al., 1999 | 23329 | |
| fibrinogen alpha chain precursor | P02671 | 19-866 | peptide-Arg35+Gly-peptide | P | Gly | Gly | Val | Arg | Gly | Pro | Arg | Val | Yuan et al., 2009 | 24714 | ||
| fibrinogen alpha chain precursor | P02671 | 19-866 | peptide-Arg38+Val-peptide | P | Arg | Gly | Pro | Arg | Val | Val | Glu | Arg | Yuan et al., 2009 | 24715 | ||
| fibrinogen beta chain | P02675 | 31-491 | peptide-Lys163+Asp-peptide | P | NT | Lys | Gln | Val | Lys | Asp | Asn | Glu | Asn | Bini et al., 1999 | 23356 | |
| fibrinogen beta chain | P02675 | 31-491 | peptide-Lys83+Lys-peptide | P | Ala | Thr | Gln | Lys | Lys | Val | Glu | Arg | Yuan et al., 2009 | 24717 | ||
| fibrinogen beta chain | P02675 | 31-491 | peptide-Arg72+Ala-peptide | P | Gly | Gly | Tyr | Arg | Ala | Arg | Pro | Ala | Yuan et al., 2009 | 24718 | ||
| fibrinogen beta chain | P02675 | 31-491 | peptide-Lys77+Ala-peptide | P | Arg | Pro | Ala | Lys | Ala | Ala | Ala | Thr | Yuan et al., 2009 | 24719 | ||
| fibrinogen beta chain | P02675 | 31-491 | peptide-Lys51+Lys-peptide | P | Pro | Leu | Asp | Lys | Lys | Arg | Glu | Glu | Yuan et al., 2009 | 24720 | ||
| fibrinogen gamma chain | P02679 | 27-453 | peptide-Lys382+Ala-peptide | P | Thr | Tyr | Ser | Lys | Ala | Ser | Thr | Pro | Yuan et al., 2009 | 24721 | ||
| fibrinogen gamma chain | P02679 | 27-453 | peptide-Lys399+Thr-peptide | P | Ala | Thr | Trp | Lys | Thr | Arg | Trp | Tyr | Yuan et al., 2009 | 24723 | ||
| fibrinogen gamma chain | P02679 | 27-453 | peptide-Lys88+Ala-peptide | P | Gln | Leu | Ile | Lys | Ala | Ile | Gln | Leu | Yuan et al., 2009 | 23369 | ||
| fibrinogen gamma chain | P02679 | 27-453 | peptide-Lys111+Ser-peptide | P | Ala | Thr | Leu | Lys | Ser | Arg | Lys | Met | Yuan et al., 2009 | 23366 | ||
| Fibulin-2 | P37889-1 | 27-1221 | peptide-Lys263+Ala-peptide | P | NT | Val | Gln | Ala | Lys | Ala | Arg | Arg | Val | Sasaki et al., 1996 | ||
| Fibulin-2 | P37889-1 | 27-1221 | peptide-Arg406+Ala-peptide | P | NT | Pro | Arg | Phe | Arg | Ala | Glu | Glu | Asp | Sasaki et al., 1996 | ||
| Fibulin-2 | P37889-1 | 27-1221 | peptide-Arg565+Arg-peptide | P | NT | Ala | Ala | Pro | Arg | Arg | Val | Ser | Glu | Sasaki et al., 1996 | ||
| Fibulin-2 | P37889-1 | 27-1221 | peptide-Arg575+Glu-peptide | P | NT | Met | Ala | Ser | Arg | Glu | Ala | Leu | Ser | Sasaki et al., 1996 | ||
| Fibulin-2 | P37889-1 | 27-1221 | peptide-Arg652+Ser-peptide | P | NT | Ser | Ala | Pro | Arg | Ser | Glu | Ser | Ala | Sasaki et al., 1996 | ||
| fibulin-2 | P37889 | 27-1221 | peptide-Lys784+Ala-peptide | P | NT | Gln | Cys | Tyr | Lys | Ala | Leu | Thr | Cys | Sasaki et al., 1996 | ||
| glutamate [NMDA] receptor subunit epsilon-1 | Q12879 | 23-1464 | peptide-Lys317+Ala-peptide | P | NT | Pro | Glu | Ala | Lys | Ala | Ser | Cys | Tyr | Yuan et al., 2009 | 24704 | |
| hemagglutinin precursor | P03437 | 17-566 | peptide-Arg345+Gly-peptide | N | Lys | Gln | Thr | Arg | Gly | Leu | Phe | Gly | Murakami et al., 2001 | |||
| histidine-rich glycoprotein precursor | Q28640 | 9-526 | peptide-Arg303+His-peptide | N | Pro | Arg | Cys | Arg | His | Arg | Pro | Phe | Borza et al., 1996 | 17430 | ||
| histidine-rich glycoprotein precursor | Q28640 | 9-526 | peptide-Lys421+Glu-peptide | N | Pro | Ser | His | Lys | Glu | Gly | Pro | Gln | Borza et al., 1996 | 17431 | ||
| Hyaluronan and proteoglycan link protein 1 | P10915 | 16-354 | Peptide-Arg28+Ala-Peptide | N | NT | Asp | His | Asp | Arg | Ala | Ile | His | Ile | Nguyen et al., 1991 | ||
| IgG1 heavy chain (hinge region) | P01857 | 1-330 | peptide-Lys4+Thr-peptide | P | Ser | Cys | Asp | Lys | Thr | His | Thr | Cys | Ryan et al., 2008 | 20259 | ||
| insulin-like growth factor binding protein 3 | P17936 | 28-291 | peptide-Arg122+Leu-peptide | P | Ala | Val | Ser | Arg | Leu | Arg | Ala | Tyr | Lalou et al., 1997 | 3418 | ||
| insulin-like growth factor binding protein 3 | P17936 | 28-291 | peptide-Lys187+Val-peptide | P | Gln | Arg | Tyr | Lys | Val | Asp | Tyr | Glu | Lalou et al., 1997 | 3420 | ||
| insulin-like growth factor binding protein 3 | P17936 | 28-291 | peptide-Lys225+Phe-peptide | P | Asn | His | Leu | Lys | Phe | Leu | Asn | Val | Lalou et al., 1997 | |||
| insulin-like growth factor binding protein 3 | P17936 | 28-291 | peptide-Lys247+Lys-peptide | P | Gly | Phe | Tyr | Lys | Lys | Lys | Gln | Cys | Lalou et al., 1997 | |||
| insulin-like growth factor binding protein 3 | P17936 | 28-291 | peptide-His169+Ser-peptide | P | His | Pro | Leu | His | Ser | Lys | Ile | Ile | Lalou et al., 1997 | |||
| insulin-like growth factor binding protein 3 | P17936 | 28-291 | peptide-Arg185+Tyr-peptide | P | Asp | Ser | Gln | Arg | Tyr | Lys | Val | Asp | Lalou et al., 1997 | |||
| insulin-like growth factor binding protein 3 | P17936 | 28-291 | peptide-Arg124+Ala-peptide | P | Ser | Arg | Leu | Arg | Ala | Tyr | Leu | Leu | Gibson & Cohen, 1999 | 3423 | ||
| kallikrein-related peptidase 11 isoform 2 | Q9UBX7 | 51-282 | peptide-Arg188+Leu-peptide | P | Pro | Gln | Leu | Arg | Leu | Pro | His | Thr | Luo et al., 2006 | 20974 | ||
| lysyl bond | peptide-Lys+peptide | N | - | - | NPe | Lys | CPe | - | - | - | Castellino, 2004 | |||||
| matrix metallopeptidase-1 precursor | P03956 | 20-469 | peptide-Gln99+Phe100-peptide | P | Asp | Val | Ala | Gln | Phe | Val | Leu | Thr | Cawston, 2004 | 17432 | ||
| matrix metallopeptidase-13 | P45452 | 20-471 | peptide-Lys57+Glu-peptide | P | Gly | Ile | Leu | Lys | Glu | Asn | Ala | Ala | Knauper et al., 1996 | 18319 | ||
| matrix metallopeptidase-13 | P45452 | 20-471 | peptide-Arg95+Cys-peptide | P | Lys | Lys | Pro | Arg | Cys | Gly | Val | Pro | Knauper et al., 1996 | 17964 | ||
| matrix metallopeptidase-13 | P45452 | 20-471 | peptide-Glu103+Tyr-peptide | P | Asp | Val | Gly | Glu | Tyr | Asn | Val | Phe | Knauper et al., 1996 | 17965 | ||
| membrane-type matrix metallopeptidase-1 precursor | P50281 | 21-582 | peptide-Arg108+Arg-peptide | P | Ala | Asn | Val | Arg | Arg | Lys | Arg | Tyr | Okumura et al., 1997 | 18141 | ||
| membrane-type matrix metallopeptidase-1 precursor | P50281 | 21-582 | peptide-Arg111+Tyr-peptide | P | Arg | Arg | Lys | Arg | Tyr | Ala | Ile | Gln | Okumura et al., 1997 | 18142 | ||
| MEP1A | Q8TDC9 | 1-746 | peptide-Arg65+Asn-peptide | P | Gln | Lys | Ser | Arg | Asn | Gly | Leu | Arg | Rösmann et al., 2002 | 3415 | ||
| neural cell adhesion molecule L1 | P32004 | 20-1257 | peptide-Lys860+His-peptide | P | Ser | Gln | Arg | Lys | His | Ser | Lys | Arg | Nayeem et al., 1999 | 19502 | ||
| neural cell adhesion molecule L1 | P32004 | 20-1257 | peptide-Lys863+Arg-peptide | P | Lys | His | Ser | Lys | Arg | His | Ile | His | Nayeem et al., 1999 | 19503 | ||
| nidogen-1 | P10493 | 29-1245 | peptide-Lys231+Ser-peptide | P | Phe | Leu | Trp | Lys | Ser | Asn | Gly | Ala | Walker et al., 1998 | 26821 | ||
| nidogen-1 | P10493 | 29-1245 | peptide-Arg349+Ser-peptide | P | Glu | Arg | Thr | Arg | Ser | Phe | Gln | Leu | Walker et al., 1998 | 26822 | ||
| osteocalcin | P02818 | 52-100 | peptide-Arg94+Arg-peptide | P | Glu | Ala | Tyr | Arg | Arg | Phe | Tyr | Gly | Yuan et al., 2009 | 24726 | ||
| osteopontin | P10451 | 17-314 | peptide-Arg168+Ser-peptide | P | NT | Tyr | Gly | Leu | Arg | Ser | Lys | Ser | Lys | Christensen et al., 2010 | ||
| osteopontin | P10451 | 17-314 | peptide-Lys170+Ser-peptide | P | NT | Leu | Arg | Ser | Lys | Ser | Lys | Lys | Phe | Christensen et al., 2010 | ||
| osteopontin | P10451 | 17-314 | peptide-Asp178+Ile-peptide | P | NT | Arg | Arg | Pro | Asp | Ile | Gln | Tyr | Pro | Christensen et al., 2010 | ||
| osteopontin | P10451 | 17-314 | peptide-Lys203+Ala-peptide | P | NT | Gly | Ala | Tyr | Lys | Ala | Ile | Pro | Val | Christensen et al., 2010 | ||
| placenta growth factor isoform PIGF-4 | P49763 | 19-221 | peptide-Lys208+Met-peptide | P | NT | Leu | Arg | Glu | Lys | Met | Lys | Pro | Glu | Kunnapuu et al., 2021 | ||
| plasminogen | P00747 | 20-810 | peptide-Lys77+Lys-peptide | P | Leu | Phe | Glu | Lys | Lys | Val | Tyr | Leu | Castellino, 2004 | 17433 | ||
| plasminogen | P00747 | 20-810 | peptide-Lys487+Gly-peptide | P | Gly | Asn | Gly | Lys | Gly | Tyr | Arg | Gly | Kwon et al., 2005 | 18916 | ||
| proteinase-activated receptor 1 | P25116 | 27-425 | peptide-Lys32+Ala-peptide | P | Pro | Glu | Ser | Lys | Ala | Thr | Asn | Ala | Loew et al., 2000 | 24706 | ||
| proteinase-activated receptor 1 | P25116 | 27-425 | peptide-Arg70+Leu-peptide | P | Thr | Glu | Tyr | Arg | Leu | Val | Ser | Ile | Loew et al., 2000 | 24708 | ||
| proteinase-activated receptor 1 | P25116 | 27-425 | peptide-Lys76+Ser-peptide | P | Ser | Ile | Asn | Lys | Ser | Ser | Pro | Leu | Loew et al., 2000 | 24709 | ||
| proteinase-activated receptor 1 | P25116 | 27-425 | peptide-Arg41+Ser-peptide | P | Leu | Asp | Pro | Arg | Ser | Phe | Leu | Leu | Loew et al., 2000 | 24707 | ||
| proteinase-activated receptor 1 | P25116 | 27-425 | peptide-Lys82+Gln-peptide | P | Pro | Leu | Gln | Lys | Gln | Leu | Pro | Ala | Steinberg, 2004 | 24710 | ||
| proteinase-activated receptor 2 | P55085 | 26-397 | peptide-Lys34+Gly-peptide | P | Arg | Ser | Ser | Lys | Gly | Arg | Ser | Leu | Loew et al., 2000 | 3427 | ||
| proteinase-activated receptor 2 | P55085 | 26-397 | peptide-Arg36+Ser-peptide | P | Ser | Lys | Gly | Arg | Ser | Leu | Ile | Gly | Loew et al., 2000 | 3424 | ||
| proteinase-activated receptor 4 precursor | Q96RI0 | 18-385 | peptide-Arg47+Gly-peptide | P | Pro | Ala | Pro | Arg | Gly | Tyr | Pro | Gly | Steinberg, 2004 | 20887 | ||
| retinoic acid receptor responder protein 2 precursor | Q99969 | 17-163 | peptide-Lys158+Ala-peptide | P | Ala | Phe | Ser | Lys | Ala | Leu | Pro | Arg | Zabel et al., 2005 | |||
| S-2238 | D-Phe-Pip-Arg+NHPhNO2 | S | - | DPh | Pip | Arg | NAN | - | - | - | ||||||
| S-2251 | D-Val-Leu-Lys+NHPhNO2 | S | - | DVa | Leu | Lys | NAN | - | - | - | ||||||
| S-2266 | D-Val-Leu-Arg+NHPhNO2 | S | - | DVa | Leu | Arg | NAN | - | - | - | ||||||
| S-2302 | D-Pro-Phe-Arg+NHPhNO2 | S | - | DPr | Phe | Arg | NAN | - | - | - | ||||||
| scnn1g sodium channel, nonvoltage-gated 1 gamma | Q9WU39 | 1-655 | peptide-Lys194+Ala-peptide | P | Ile | Ile | His | Lys | Ala | Ser | Asn | Val | Passero et al., 2008 | 25557 | ||
| small-inducible cytokine A14 precursor | Q16627 | 20-93 | peptide-Arg27+Gly-peptide | P | Ser | Ser | Ser | Arg | Gly | Pro | Tyr | His | Vakili et al., 2001 | |||
| small-inducible cytokine A2 precursor | P10148 | 24-148 | peptide-Lys104+Thr-peptide | P | Thr | Leu | Phe | Lys | Thr | Ala | Ser | Ala | Sheehan et al., 2007 | |||
| syndecan-1 | P18827 | 23-310 | peptide-Arg230+Asn-peptide | P | NT | Pro | Asp | Arg | Arg | Asn | Gln | Ser | Pro | Manon-Jensen et al., 2013 | ||
| Syndecan-4 | P31431 | 19-198 | peptide-Lys114+Arg-peptide | P | Val | Ile | Pro | Lys | Arg | Ile | Ser | Pro | Schmidt et al., 2005 | 18868 | ||
| Syndecan-4 | P31431 | 19-198 | peptide-Lys128+Val-peptide | P | Val | Ser | Asn | Lys | Val | Ser | Met | Ser | Schmidt et al., 2005 | 18870 | ||
| tissue-type plasminogen activator | P00750 | 36-562 | peptide-Arg275+Ile-peptide | P | Pro | Gln | Phe | Arg | Ile | Lys | Gly | Gly | Tate et al., 1987 | 18843 | ||
| Tos-Gly-Pro-Lys-NHPhNO2 | Tos-Gly-Pro-Lys+NHPhNO2 | S | Tos | Gly | Pro | Lys | NAN | - | - | - | ||||||
| urokinase plasminogen activator surface receptor | Q03405 | 23-305 | peptide-Arg111+Ser-peptide | P | Thr | Tyr | Ser | Arg | Ser | Arg | Tyr | Leu | Andolfo et al., 2002 | 19562 | ||
| urokinase plasminogen activator surface receptor | Q03405 | 23-305 | peptide-Arg105+Ala-peptide | P | Asn | Ser | Gly | Arg | Ala | Val | Thr | Tyr | Andolfo et al., 2002 | 19939 | ||
| urokinase plasminogen activator surface receptor | P35456 | 24-298 | peptide-Arg109+Ala-peptide | P | Ala | Arg | Gly | Arg | Ala | Phe | Pro | Gln | Andolfo et al., 2002 | 19937 | ||
| urokinase plasminogen activator surface receptor | P35456 | 24-298 | peptide-Arg107+Gly-peptide | P | Pro | Gly | Ala | Arg | Gly | Arg | Ala | Phe | Andolfo et al., 2002 | |||
| urokinase-type plasminogen activator | P00749 | 21-431 | peptide-Lys158+Ile-peptide | P | Pro | Arg | Phe | Lys | Ile | Ile | Gly | Gly | Ellis, 2004 | 17436 | ||
| urokinase-type plasminogen activator | P00749 | 21-431 | peptide-Lys135+Lys-peptide | P | Ala | Asp | Gly | Lys | Lys | Pro | Ser | Ser | Ellis, 2004 | 17435 | ||
| vascular endothelial growth factor A | P15692 | 27-232 | peptide-Arg136+Ala-peptide | P | NT | Lys | Lys | Asp | Arg | Ala | Arg | Gln | Glu | Kunnapuu et al., 2021 | ||
| vascular endothelial growth factor C | P49767 | 32-111 | peptide-Arg102+Thr-peptide | P | NT | Leu | Asn | Ser | Arg | Thr | Glu | Glu | Thr | Kunnapuu et al., 2021 | ||
| vascular endothelial growth factor C | P49767 | 32-111 | peptide-Arg127+ | P | NT | Asn | Glu | Trp | Arg | '-' | '-' | '-' | '-' | Kunnapuu et al., 2021 | ||
| vascular endothelial growth factor D | O43915 | 22-354 | peptide-Arg108+Thr-peptide | P | NT | Glu | Trp | Gln | Arg | Thr | Gln | Cys | Ser | Kunnapuu et al., 2021 | ||
| vascular endothelial growth factor D precursor | O43915 | 22-354 | peptide-Arg88+Phe-peptide | P | Arg | Ser | Thr | Arg | Phe | Ala | Ala | Thr | McColl et al., 2003 | 23304 | ||
| vascular endothelial growth factor D precursor | O43915 | 22-354 | peptide-Lys100+Val-peptide | P | Glu | Thr | Leu | Lys | Val | Ile | Asp | Glu | McColl et al., 2003 | 23305 | ||
| vascular endothelial growth factor D precursor | O43915 | 22-354 | peptide-Arg205+Ser-peptide | P | Ile | Ile | Arg | Arg | Ser | Ile | Gln | Ile | McColl et al., 2003 | 23306 | ||
| vitronectin | P04004 | 20-478 | peptide-Arg361+Ser-peptide | P | Lys | Gly | Tyr | Arg | Ser | Gln | Arg | Gly | Chain et al., 1991 | 17437 |
